KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMY) Return on Equity (2016 - 2025)

Historic Return on Equity for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to 0.38%.

  • Bristol Myers Squibb's Return on Equity rose 9100.0% to 0.38% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.38%, marking a year-over-year increase of 9100.0%. This contributed to the annual value of 0.4% for FY2025, which is 6900.0% up from last year.
  • According to the latest figures from Q4 2025, Bristol Myers Squibb's Return on Equity is 0.38%, which was up 9100.0% from 0.34% recorded in Q3 2025.
  • Bristol Myers Squibb's Return on Equity's 5-year high stood at 0.38% during Q4 2025, with a 5-year trough of 0.53% in Q4 2024.
  • Its 5-year average for Return on Equity is 0.06%, with a median of 0.18% in 2021.
  • Its Return on Equity has fluctuated over the past 5 years, first plummeted by -7500bps in 2024, then skyrocketed by 9100bps in 2025.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Return on Equity stood at 0.17% in 2021, then dropped by -5bps to 0.16% in 2022, then skyrocketed by 32bps to 0.22% in 2023, then crashed by -347bps to 0.53% in 2024, then soared by 171bps to 0.38% in 2025.
  • Its last three reported values are 0.38% in Q4 2025, 0.34% for Q3 2025, and 0.29% during Q2 2025.